Reagents and models for detecting endogenous GLP1R and GIPR

Glucagon-like peptide-1 receptor (GLP1R) agonists target the GLP1R, whereas dual GLP1R/ gastric inhibitory polypeptide receptor (GIPR) agonists target both the GLP1R and GIPR. Despite the importance of these drug classes for the treatment of diabetes and obesity, still very little is known about the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ast, Julia, Broichhagen, Johannes, Hodson, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669301/
https://www.ncbi.nlm.nih.gov/pubmed/34911028
http://dx.doi.org/10.1016/j.ebiom.2021.103739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669301/
https://www.ncbi.nlm.nih.gov/pubmed/34911028
http://dx.doi.org/10.1016/j.ebiom.2021.103739

Ejemplares similares